Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer

Anticancer Research

Volumn 27, Issue 1 B, 2007, Pages 583-588

  Thiéfin, Gérard ^a,c   Dupont, Aurélie ^a   Guillou, Pierre José ^a   Vitry, Fabien ^a   Bouche, Olivier ^a   Yaziji, Nahla ^a   Lagarde, Stéphanie ^a   Maquart, François Xavier ^a   Palot, Jean Pierre ^b   Hornebeck, William ^a   Diebold, Marie Danièle ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

Colorectal cancer; Matrix metalloproteinase; Microsatellite instability; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; COLORECTAL NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOPROTEASES; MICROSATELLITE INSTABILITY; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33847701242     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lengauer C, Kinzler KW and Vogelstein B: Genetic instability in colorectal cancers. Nature 386: 623-627, 1997.
2. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R and Hawkins N: Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48: 821-829, 2001.
3. Popat S, Hubner R and Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618, 2005.
4. Giacomini CP, Leung SY, Chen X, Yue ST, Kim YH and Bair E: A gene expression signature of genetic instability in colon cancer. Cancer Res 65: 9200-9205, 2005.
5. Wagenaar-Miller RA, Gorden L and Matrisian LM: Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23: 119-135, 2004.
6. Mook ORF, Frederiks WM and Van Noorden CJF: The role of gelatinases in colorectal cancer progression and metastasis. Biochem Biophys Act 1705: 69-89, 2004.
7. Zucker S and Vacirca J: Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23: 101-117, 2004.
8. Hornebeck W, Lambert E, Petitfrère E and Bernard P: Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87: 377-383, 2005.
9. Hornebeck W, Emonard H, Monboisse JC and Bellon G: Matrix-directed regulation of pericellular proteolysis and tumor progression. Sem Cancer Biol 12: 231-241, 2002.
10. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshelman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colon cancer. Cancer Res 58: 5248-5257, 1998.
11. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Jarvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS and Aaltonen LA: Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 62: 1166-1170, 2002.
12. Oliver GW, Leferson JD, Stetler-Stevenson WG and Kleiner DE: Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem 244: 161-166, 1997.
13. Waas ET, Lomme RM, DeGroot J, Wobbes T and Hendriks T: Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 86: 1876-1883, 2002.
14. Zeng ZS, Huang Y, Cohen AM and Guillem JG: Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14: 3133-3140, 1996.
15. Zeng ZS, Cohen AM and Guillem JG: Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20: 749-755, 1999.
16. Markowitz S, Wang J, Myeroff JL, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
17. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC and Perucho M: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969, 1997.
18. Morán A, Iniesta P, de Juan C, González-Quevedo R, Sánchez-Pernaute A, Díaz-Rubio E, Ramon y Cajal S, Torres A, Balibrea JL and Benito M: Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors. Cancer Res 62: 3855-3860, 2002.
19. Sounni NE and Noel A: Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87: 329-342, 2005.
20. Kikuchi R, Noguchi T, Takeno S, Kubo N and Uchida Y: Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer 83: 215-218, 2000.
21. Morín A, Iniesta P, de Juan C, García-Aranda C, Díaz-López A and Benito M: Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors. Cancer Res 65: 3811-3814, 2005.
22. Masuda H and Aoki H: Host expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in normal colon tissue affects metastatic potential of colorectal cancer. Dis Colon Rectum 42: 393-397, 1999.
23. Hill R, Song Y, Cardiff RD and Van Dyke T: Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123: 1001-1011, 2005.